View on Pubmed.gov 25565632 | View on doi.org 10.18632/oncota...
The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling.
- The CRUK Gene Function Laboratory and Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK. Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, NE1 3BZ, UK.
- The CRUK Gene Function Laboratory and Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK.
- Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, NE1 3BZ, UK.
Abstract
CYLD, an ubiquitin hydrolase, has an expanding repertoire of regulatory roles in cell signalling and is dysregulated in a number of cancers. To dissect CYLD function we used a proteomics approach to identify CYLD interacting proteins and identified MIB2, an ubiquitin ligase enzyme involved in Notch signalling, as a protein which interacts with CYLD. Coexpression of CYLD and MIB2 resulted in stabilisation of MIB2 protein levels and was associated with reduced levels of JAG2, a ligand implicated in Notch signalling. Conversely, gene silencing of CYLD using siRNA, resulted in increased JAG2 expression and upregulation of Notch signalling. We investigated Notch pathway activity in skin tumours from patients with germline mutations in CYLD and found that JAG2 protein levels and Notch target genes were upregulated. In particular, RUNX1 was overexpressed in CYLD defective tumour cells. Finally, primary cell cultures of CYLD defective tumours demonstrated reduced viability when exposed to γ-secretase inhibitors that pharmacologically target Notch signalling. Taken together these data indicate an oncogenic dependency on Notch signalling and suggest potential novel therapeutic approaches for patients with CYLD defective tumours.
References
EMBO J. 2000 Jan 4;19(1):94-102
EMBO J. 2012 Nov 5;31(21):4124-39
Anal Chem. 2000 Jun 1;72(11):2482-9
Methods. 2001 Jul;24(3):218-29
Cited by 30 citations (total)
Journal Article Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural
The role of deubiquitinases in breast cancer.
Electronic publication date November 1, 2017
Zhenna Xiao [...] Li Ma et al.
Although growing numbers of oncoproteins and pro-metastatic proteins have been extensively characterized, many of these tumor-promoting proteins are not good...
Journal Article Review
Deubiquitinating Enzyme-Mediated Signaling Networks in Cancer Stem Cells.
Electronic publication date November 8, 2020
Kamini Kaushal [...] Suresh Ramakrishna et al.
Cancer stem cells (CSCs) have both the capacity for self-renewal and the potential to differentiate and contribute to multiple tumor...
Conflict of interest statement
MeSH
- •
- •
- •
Specialties
- •
- •
- •
- •
Substances
- •
- •
- •
- •
- •